Gene: CCDC102A
Official Full Name: coiled-coil domain containing 102Aprovided by HGNC
Gene Summary: Predicted to be part of myosin complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO22489 | CCDC102A Knockout cell line (HeLa) | Human | CCDC102A | 1:3~1:6 | Negative | Online Inquiry |
KO22490 | CCDC102A Knockout cell line (HCT 116) | Human | CCDC102A | 1:2~1:4 | Negative | Online Inquiry |
KO22491 | CCDC102A Knockout cell line (HEK293) | Human | CCDC102A | 1:3~1:6 | Negative | Online Inquiry |
KO22492 | CCDC102A Knockout cell line (A549) | Human | CCDC102A | 1:3~1:4 | Negative | Online Inquiry |
CCDC102A Gene Knockout Cell Lines are specifically engineered cell lines featuring targeted disruptions in the CCDC102A gene. This gene is implicated in various cellular processes and is under investigation for its roles in cellular differentiation and potential disease mechanisms, including cancer and other genetic disorders. By utilizing CRISPR-Cas9 gene-editing technology, these cell lines provide a powerful tool for elucidating the functional consequences of CCDC102A loss-of-function, allowing researchers to dissect its biological pathways with unprecedented precision.
The primary function of CCDC102A Gene Knockout Cell Lines is to serve as a model system for studying the gene's role in cellular physiology and pathology. By knocking out CCDC102A expression, these cell lines enable scientists to observe the resulting phenotypic changes, alterations in signaling pathways, and impacts on cell growth, motility, and apoptosis. This mechanistic understanding is crucial for advancing therapeutic strategies aimed at diseases associated with dysregulated CCDC102A function.
The scientific importance of these knockout cell lines extends to a variety of research applications, including cancer biology, developmental studies, and the investigation of genetic disorders. Their adaptability in laboratory settings allows researchers to explore gene function in various contexts, from basic research to drug screening and validation.
Compared to traditional wild-type cell lines, CCDC102A Gene Knockout Cell Lines offer distinct advantages, such as the lack of confounding variable effects associated with gene expression variability. They afford researchers a clearer and more reliable assessment of gene function and potential therapeutic targets, thereby enhancing study reproducibility and reliability.
For researchers and clinicians aiming to develop targeted gene therapies or identify biomarkers for therapeutic interventions, CCDC102A Gene Knockout Cell Lines present a unique and valuable resource. Their specificity and reliability enable straightforward experimental designs and interpretations that broaden the understanding of CCDC102A-related pathways.
With extensive expertise in molecular biology and a commitment to advancing scientific research, our company provides high-quality biological products, including CCDC102A Gene Knockout Cell Lines, designed to facilitate groundbreaking discoveries in genetics and beyond.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.